Correlation Between Mink Therapeutics and Apogee Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Mink Therapeutics and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mink Therapeutics and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mink Therapeutics and Apogee Therapeutics, Common, you can compare the effects of market volatilities on Mink Therapeutics and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mink Therapeutics with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mink Therapeutics and Apogee Therapeutics,.
Diversification Opportunities for Mink Therapeutics and Apogee Therapeutics,
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Mink and Apogee is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and Mink Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mink Therapeutics are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of Mink Therapeutics i.e., Mink Therapeutics and Apogee Therapeutics, go up and down completely randomly.
Pair Corralation between Mink Therapeutics and Apogee Therapeutics,
Given the investment horizon of 90 days Mink Therapeutics is expected to under-perform the Apogee Therapeutics,. In addition to that, Mink Therapeutics is 1.01 times more volatile than Apogee Therapeutics, Common. It trades about -0.26 of its total potential returns per unit of risk. Apogee Therapeutics, Common is currently generating about 0.09 per unit of volatility. If you would invest 4,396 in Apogee Therapeutics, Common on September 27, 2024 and sell it today you would earn a total of 336.00 from holding Apogee Therapeutics, Common or generate 7.64% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Mink Therapeutics vs. Apogee Therapeutics, Common
Performance |
Timeline |
Mink Therapeutics |
Apogee Therapeutics, |
Mink Therapeutics and Apogee Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mink Therapeutics and Apogee Therapeutics,
The main advantage of trading using opposite Mink Therapeutics and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mink Therapeutics position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.Mink Therapeutics vs. Affimed NV | Mink Therapeutics vs. Adaptimmune Therapeutics Plc | Mink Therapeutics vs. Sangamo Therapeutics | Mink Therapeutics vs. Day One Biopharmaceuticals |
Apogee Therapeutics, vs. Fate Therapeutics | Apogee Therapeutics, vs. Caribou Biosciences | Apogee Therapeutics, vs. Karyopharm Therapeutics | Apogee Therapeutics, vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |